Results 241 to 250 of about 6,465,161 (268)

Clinical and Modifiable Factors Associated With Disability and Relapse in MOGAD: A Multicentre Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang   +23 more
wiley   +1 more source

MYO18A Expression is a Prognostic Factor for Progression-Free Survival in Grade 4 Adult gliomas. Preliminary Report. [PDF]

open access: yesOncol Res
Strąk A   +12 more
europepmc   +1 more source

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study. [PDF]

open access: yesEClinicalMedicine
Richardson S   +27 more
europepmc   +1 more source

Automated Pretreatment Thoracic CT-Based Body Composition Analysis Predicts Progression-Free Survival in Head and Neck Cancer. [PDF]

open access: yesJ Clin Med
Jungbauer F   +14 more
europepmc   +1 more source

Disturbance of functional connectivity in patients with low grade glioma is associated with worse progression-free survival. [PDF]

open access: yesNeurooncol Adv
Stoecklein VM   +15 more
europepmc   +1 more source

Predicting progression-free survival in glioblastoma: influence of the perilesional oedema and white-matter disconnectome

open access: yes
Tariq M   +10 more
europepmc   +1 more source

Health Insurance Status and Cancer Stage at Diagnosis and Survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Leticia Nogueira   +2 more
exaly  

Home - About - Disclaimer - Privacy